1. Background
=============

Many drugs have been recommended for the attenuation of haemodynamic response during intubation and extubation of the trachea like remifentanil ([@A63490REF1]), lidocaine ([@A63490REF2]), magnesium sulfate ([@A63490REF3]), clonidine ([@A63490REF4]) esmolol ([@A63490REF5]), and dexmedetomidine ([@A63490REF6]). Recent studies have demonstrated that perioperative lignocaine infusion is also useful in reducing postoperative pain ([@A63490REF7]-[@A63490REF10]). Very few previous studies have demonstrated both the effect of lignocaine infusion that is attenuation of haemodynamic response to intubation and extubation of trachea and postoperative analgesia ([@A63490REF11]-[@A63490REF13]). Present trend for perioperative analgesia is multimodal ([@A63490REF14]). Intravenous lignocaine has found to be useful in attenuation of haemodynamic response and for postoperative analgesia as well ([@A63490REF15], [@A63490REF16]). In our present study we want to evaluate both the effect of perioperative infusion of lignocaine that is attenuation of haemodynamic response to intubation and extubation of trachea and postoperative analgesia for laparoscopic cholecystectomy surgeries.

2. Methods
==========

After obtaining approval of the institutional ethics committee, double blinded randomized controlled study was done on a total 130 patients. Written informed consent was taken from all patients. Patients aged between 30 - 60 years as well as the American society of anaesthesiology class I and class II patients were considered. Patients with cardio‐respiratory, renal, hepatic or endocrine disease, those having predicted difficult tracheal intubation, body mass index more than 30, whenever the surgical procedure necessitated the conversion of laparoscopic to open cholecystectomy, or surgical time exceeded 180 minutes were excluded from the study.

Group A (n = 65): 0.9% normal saline was used as placebo for perioperative intravenous infusion. Group B (n = 65): preservative free lignocaine diluted with normal saline and made to 1% used as intravenous infusion started at a dose of 1.5 mg per kg as bolus over 10 minutes to induction and then 1.5 mg/kg/h. infusion till 1 hour postoperatively. Total duration of infusion is limited to 180 minutes as a safeguard against potential lignocaine toxicity. Intraoperative monitoring was done with HR, oxygen saturation, electrocardiogram, MBP, temperature, end tidal carbon dioxide, and minimum alveolar concentration.

Sample size in each group was calculated using the n = 2σ^2^ (Z~α~ + Z~β~)^2^/Δ^2^ formula. All data were entered in the Windows Microsoft Excel sheet and an analysis was done with SPSS version 16. All continuous variables that met the assumptions of the normality were expressed as median or mean + standard deviation. Categorical variables were expressed as proportion or percentage. Normally distributed continuous variables were compared by "t" test. Based on the number of observations, present categorical comparisons were done by Fisher's exact or Chi-square test. All values were considered if P \< 0.05 significant statistically.

3. Results
==========

Demographic characteristics of both groups were statistically comparable ([Table 1](#A63490TBL1){ref-type="table"}).

###### Demographic Data^[a](#A63490TBL1FN1){ref-type="table-fn"}^

                                 Group A (n = 65)   Group B (n = 65)   P Value
  ------------------------------ ------------------ ------------------ ---------
  **Age, y**                     44.3 ± 5.35        45.5 ± 6.80        0.378
  **Gender, (F/M)**              29/36              27/38              0.652
  **BMI, kg/m** ^**2**^          26.9 ± 4.23        27.1 ± 3.34        0.496.
  **ASA distribution I/II**      38/27              36/29              0.652
  **Duration of surgery, min**   104 ± 8            112 ± 11           0.433

^a^Values are expressed as mean ± standard deviation or No. (%).

Comparison of heart rate (HR) and mean arterial pressure (MAP) at baseline and after intubation are given in [Tables 2](#A63490TBL2){ref-type="table"} and [3](#A63490TBL3){ref-type="table"}, respectively.

###### Comparison of Heart Rate (HR) at Baseline and After Intubation of Trachea

                                  Group A (65)    Group B (65)    P Value
  ------------------------------- --------------- --------------- ----------
  **Baseline HR**                 73.43 ± 4.81    71.78 ± 4.29    0.050
  **HR 1 min after intubation**   112.23 ± 5.98   100.88 ± 6.37   \< 0.001
  **HR 3 min after intubation**   102.56 ± 7.21   92.11 ± 4.47    \< 0.001
  **HR 5 min after intubation**   91.18 ± 5.28    85.05 ± 4.63    \< 0.001

^a^Values are expressed as mean ± standard deviation.

###### Comparison of Mean Arterial Pressure (MAP) at Baseline and After Intubation of Trachea^[a](#A63490TBL3FN1){ref-type="table-fn"}^

                                   Group A (65)    Group B (65)    P Value
  -------------------------------- --------------- --------------- ----------
  **Baseline MAP**                 84.55 ± 5.27    85.96 ± 4.57    0.11
  **MAP 1 min after intubation**   123.18 ± 6.21   110.13 ± 6.16   \< 0.001
  **MAP 3 min after intubation**   112.71 ± 9.29   100.98 ± 5.52   \< 0.001
  **MAP 5 min after intubation**   100.11 ± 7.37   93.38 ± 4.25    \< 0.001

^a^Values are expressed as mean ± standard deviation.

Comparison of heart rate (HR) and mean arterial pressure (MAP) between the groups after extubation of trachea are given in [Tables 4](#A63490TBL4){ref-type="table"} and [5](#A63490TBL5){ref-type="table"}.

###### Comparison of Heart Rate (HR) after Extubation of Trachea^[a](#A63490TBL4FN1){ref-type="table-fn"}^

                                  Group A (65)   Group B (65)    P Value
  ------------------------------- -------------- --------------- ----------
  **HR 1 min after extubation**   112.3 ± 6.04   101.11 ± 6.51   \< 0.001
  **HR 3 min after extubation**   102.7 ± 7.20   92.2 ± 4.43     \< 0.001
  **HR 5 min after extubation**   91.25 ± 5.29   85.11 ± 4.55    \< 0.001

^a^Values are expressed as mean ± standard deviation.

###### Comparison of Mean Arterial Pressure (MAP) After Extubation of Trachea^[a](#A63490TBL5FN1){ref-type="table-fn"}^

                                   Group A (65)    Group B (65)   P Value
  -------------------------------- --------------- -------------- ----------
  **MAP 1 min after extubation**   123.11 ± 6.23   110.2 ± 6.1    \< 0.001
  **MAP 3 min after extubation**   112.8 ± 9.21    101.1 ± 5.4    \< 0.001
  **MAP 5 min after extubation**   100.18 ± 7.35   93.43 ± 4.23   \< 0.001

^a^Values are expressed as mean ± standard deviation.

Comparison of Visual Analog Scale (VAS) and pain free period between the groups are given in [Tables 6](#A63490TBL6){ref-type="table"} and [7](#A63490TBL7){ref-type="table"}.

###### Comparison of Visual Analog Scale (VAS) Between the Groups^[a](#A63490TBL6FN1){ref-type="table-fn"}^

                         Group A (65)   Group B (65)   P Value
  ---------------------- -------------- -------------- ----------
  **VAS at 30 minute**   1.32 ± 0.54    0.38 ± 0.49    \< 0.001
  **VAS at 1 hour**      4.38 ± 0.55    1.17 ± 0.668   \< 0.001

^a^Values are expressed as mean ± standard deviation.

###### Comparison of Pain Free Period^[a](#A63490TBL7FN1){ref-type="table-fn"}^

                         Group A (65)   Group B (65)     P Value
  ---------------------- -------------- ---------------- ----------
  **Pain free period**   49.85 ± 6.37   227.36 ± 11.62   \< 0.001

^a^Values are expressed as mean ± standard deviation.

4. Discussion
=============

Our study has found no statistically significant rise in mean MAP and mean HR during intubation of tracheal and extubation of the trachea between the study groups. Previous studies have found that intravenous infusion of lignocaine attenuates haemodynamic response associated with intubation and extubation of trachea ([@A63490REF1], [@A63490REF5]-[@A63490REF8]). The combination of verapamil with lignocaine ([@A63490REF7]) and also drugs like diltiazem ([@A63490REF6]) have also found to attenuate haemodynamic response. Many previous studies show lignocaine infusion being used for postoperative pain relief ([@A63490REF9]-[@A63490REF11]). Our study also shows that the postoperative pain free period was significantly more in the Group B. A systemic review on intravenous lignocaine infusion preoperatively concluded that there was a decreased anaesthetic drug requirement intraoperatively, decreased requirement of postoperative analgesics, and also had lower pain scores ([@A63490REF12]).

4.1. Conclusions
----------------

Perioperative intravenous infusion of lignocaine attenuates haemodynamic response during intubation and extubation of trachea and also postoperatively was an increase in the mean pain free period.
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